Xtrackers MSCI All China Equity ETF
CN was delisted on the 13th of March, 2024.
6 hedge funds and large institutions have $4.36M invested in Xtrackers MSCI All China Equity ETF in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
0% more funds holding
Funds holding: 6 → 6 (0)
1% less capital invested
Capital invested by funds: $4.43M → $4.36M (-$66K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
Cetera Advisors
Denver,
Colorado
|
+$1.94M |
| 2 |
Jane Street
New York
|
+$278K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.46K |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
+$31 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$2.88M |
CN Hedge Fund Activity: Q4 2014 in Review
6 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Xtrackers MSCI All China Equity ETF (CN) for Q4 2014, worth a combined $4.36M — down 1.5% from $4.43M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CN positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Cetera Advisors, adding an estimated $1.94M. The largest seller was Goldman Sachs, exiting entirely with an estimated $2.88M sold.
- 6 institutional investors held Xtrackers MSCI All China Equity ETF (CN) as of Q4 2014, unchanged from Q3 2014.
- Funds reported $4.36M of Xtrackers MSCI All China Equity ETF stock for Q4 2014, down 1.5% quarter-over-quarter.
- 2 funds opened new Xtrackers MSCI All China Equity ETF positions in Q4 2014 and 1 closed out, a net change of +1 holder.
- The largest Xtrackers MSCI All China Equity ETF buyer in Q4 2014 was Cetera Advisors, an estimated $1.94M added.
- The largest Xtrackers MSCI All China Equity ETF seller in Q4 2014 was Goldman Sachs, an estimated $2.88M sold.
Based on aggregated 13F filings for Q4 2014.